Effect of Treatment on Natriuretic Peptide
There was a significant reduction in NTproBNP over time observed in the sacubitril/valsartan vs valsartan group, which was sustained throughout the study (In post hoc analyses, small but significant differences between the 2 groups at baseline were noted in the mean (SD) body surface area among those who attended for cardiac MRI (sacubitril/valsartan 1.96 [0.22] m